Toggle navigation
Browse
Home
People
Departments & Colleges
Research
Research Area Overlaps
Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC
Article (Web of Science)
Industry Collaboration
International Collaboration
Overview
Research
Additional Document Info
View All
Overview
cited authors
Antonia, Scott J.; Balmanoukian, Ani; Brahmer, Julie; Ou, Sai-Hong I.; Hellmann, Matthew D.; Kim, Sang-We; Ahn, Myung-Ju; Kim, Dong-Wan; Gutierrez, Martin; Liu, Stephen V.; Schoffski, Patrick; Jaeger, Dirk; Jamal, Rahima; Jerusalem, Guy; Lutzky, Jose; Nemunaitis, John; Calabro, Luana; Weiss, Jared; Gadgeel, Shirish; Bhosle, Jaishree; Ascierto, Paolo A.; Rebelatto, Marlon C.; Narwal, Rajesh; Liang, Meina; Xiao, Feng; Antal, Joyce; Abdullah, Shaad; Angra, Natasha; Gupta, Ashok K.; Khleif, Samir N.; Segal, Neil H.
publication date
October 1, 2019
webpage
Web of Science
published in
JOURNAL OF THORACIC ONCOLOGY
Journal
Research
category
RESPIRATORY SYSTEM
Category
keywords
Durvalumab
Efficacy
Immunotherapy
NSCLC
Safety
Additional Document Info
start page
1794
end page
1806
volume
14
issue
10